Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Social Psychiatry and Psychiatric Epidemiology
Published in: Social Psychiatry and Psychiatric Epidemiology 3/2012

01-03-2012 | Original Paper

Who receives depression-specific treatment? A secondary data-based analysis of outpatient care received by over 780,000 statutory health-insured individuals diagnosed with depression

Authors: Stefanie Boenisch, Rueya-Daniela Kocalevent, Herbert Matschinger, Roland Mergl, Claudia Wimmer-Brunauer, Martin Tauscher, Dietmar Kramer, Ulrich Hegerl, Anke Bramesfeld

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 3/2012

Login to get access

Abstract

Purpose

This study examined the effects of individual and regional characteristics on receiving depression-specific treatment in the statutory health-insured population of Bavaria (83% of the population).

Methods

Data of the Association of Statutory Health Insurance Physicians in Bavaria were analysed for prevalence, diagnosis of and treatment for depression in outpatient care by considering individual and regional characteristics.

Results

Prevalence of diagnosed depression was 9.2% for the statutory health-insured population aged 18–100 years. More than half of all individuals diagnosed with depression (F32.x/F33.x) and more than one-third of persons diagnosed with severe depression (F32.2/.3 and F33.2/.3) did not receive depression-specific treatment. Rates of a depression-specific treatment were higher for females, the middle aged, individuals with more severe depression diagnoses, those with psychiatric comorbidity and those without physical comorbidity and for individuals living in more rural areas.

Conclusions

The pathways to depression-specific treatment for persons diagnosed with moderate and severe depression need to be improved. Training for physicians, stepped care approaches, psycho-education for patients and anti-stigma campaigns are possible measures to reach this goal. The knowledge on individual characteristics that influence receiving a depression-specific treatment is important to target the groups at increased risk for under-treatment.
Literature
1.
Alonso J, Angermeyer MC, Bernert S et al (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109:21–27CrossRef
2.
Wittchen H-U, Jacobi F (2005) Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 15(4):357–376PubMedCrossRef
3.
Jacobi F, Klose M, Wittchen H-U (2004) Mental disorders in the community: healthcare utilization and disability days. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47(8):736–744PubMed
4.
Bramesfeld A, Grobe T, Schwartz FW (2007) Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany. Soc Psychiatry Psychiatr Epidemiol 42(9):740–746PubMedCrossRef
5.
Bramesfeld A, Grobe T, Schwartz FW (2010) Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data. Soc Psychiatry Psychiatr Epidemiol 45:329–335PubMedCrossRef
6.
Friemel S, Bernert S, Angermeyer MC, König HH (2005) The direct costs of depressive disorders in Germany. Psychiatr Prax 32(3):113–121PubMedCrossRef
7.
Mathers CD, Lopez AD, Murray CJL (2006) The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez AD et al. (eds) Global burden of disease
8.
Gesundheitswesen. In: Statistical yearbook 2008 for the Federal Republic of Germany. Wiesbaden
9.
Wang JL (2004) Rural-urban differences in the prevalence of major depression and associated impairment. Soc Psychiatry Psychiatr Epidemiol 39:19–25PubMedCrossRef
10.
Hu T, He Y, Zhang M, Chen N (2007) Economic costs of depression in China. Soc Psychiatry Psychiatr Epidemiol 42:110–116PubMedCrossRef
11.
Thase ME, Friedman ES, Biggs MM et al (2007) Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. Am J Psychiatry 164(5):739–752PubMedCrossRef
12.
DeRubeis RJ, Hollon SD, Amsterdam JD et al (2005) Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 62(4):409–416PubMedCrossRef
13.
Casacalenda N, Perry JC, Looper K (2002) Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry 159(8):1354–1360PubMedCrossRef
14.
DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD (1999) Medications versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry 156(7):1007–1013PubMed
15.
Mojtabai R, Olfson M (2006) Treatment seeking for depression in Canada and the United States. Psychiatr Serv 57(5):631–639PubMedCrossRef
16.
Parikh SV, Lesage AD, Kennedy SH, Goering PN (1999) Depression in Ontario: under-treatment and factors related to antidepressant use. J Affect Disord 52(1–3):67–76PubMedCrossRef
17.
Fernandez A, Haro JM, Martinez-Alonso M et al (2007) Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry 190:172–173PubMedCrossRef
18.
Wittchen H-U, Schuster P, Pfister H, Muller N, Storz S, Isensee B (1999) Depressive disorders in the general population—poorly recognized and rarely treated. Nervenheilkunde 18(4):202–209
19.
Spijker J, Bijl RV, de Graaf R, Nolen WA (2001) Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scan 104(1):19–24CrossRef
20.
Kessler RC, Zhao SY, Katz SJ et al (1999) Past-year use of outpatient services for psychiatric problems in the national comorbidity survey. Am J Psychiatry 156(1):115–123PubMed
21.
Rost K, Zhang ML, Fortney J, Smith J, Smith GR (1998) Rural-urban differences in depression treatment and suicidality. Med Care 36(7):1098–1107PubMedCrossRef
22.
Rush AJ, Wisniewski SR, Warden D et al (2008) Selecting among second-step antidepressant medication monotherapies Predictive value of clinical, or first-step treatment features. Arch Gen Psychiatry 65(8):870–881PubMedCrossRef
23.
Gesetzliche Krankenversicherungen: Kennzahlen und Faustformeln, 2009
24.
Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Twelve-month use of Mental Health Services in the United States—results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):629–640PubMedCrossRef
25.
Kessler RC, Berglund P, Demler O et al (2003) The epidemiology of major depressive disorder—results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095–3105PubMedCrossRef
26.
27.
28.
29.
National Collaborating Centre for Mental Health (2004) Depression: management of depression in primary and secondary care—National Clinical Practice Guideline Number 23: The British Psychological Society and Gaskell
30.
31.
Heck RH. (2001) Multilevel Modeling with SEM. In: Marcoulides GA, Schumacker RE (eds) New developments and techniques in structural equation modeling. Erlbaum, Mahwah
32.
Heck RH, Thomas SL (2009) An introduction to multilevel modeling techniques. 2nd (edn). Quantitative methodology series. Routledge, New York
33.
Muthen LK, Muthen BO (2007) Mplus user’s guide, 5th edn. Muthén & Muthén, CA
34.
S3-Leitlinie/Nationale Versorgungsleitlinie Unipolare Depression: Langfassung, 1st edn. Berlin; Düsseldorf; 2009
35.
Palsson SP, Ostling S, Skoog I (2001) The incidence of first-onset depression in a population followed from the age of 70 to 85. Psychol Med 31(7):1159–1168PubMedCrossRef
36.
Hegerl U, Althaus D, Schmidtke A, Niklewski G (2006) The alliance against depression: 2-year evaluation of a community-based intervention to reduce suicidality. Psychol Med 36(9):1225–1233PubMedCrossRef
37.
van Straten A, Cuijpers P, Smits N (2008) Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: randomized controlled trial. J Med Internet Res 10(1):e7PubMedCrossRef
38.
Veer-Tazelaar PJ Van’t; Marwijk HW Van, Oppen P Van et al (2009) Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. Arch Gen Psychiatry 66(3):297–304
Metadata
Title
Who receives depression-specific treatment? A secondary data-based analysis of outpatient care received by over 780,000 statutory health-insured individuals diagnosed with depression
Authors
Stefanie Boenisch
Rueya-Daniela Kocalevent
Herbert Matschinger
Roland Mergl
Claudia Wimmer-Brunauer
Martin Tauscher
Dietmar Kramer
Ulrich Hegerl
Anke Bramesfeld
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Social Psychiatry and Psychiatric Epidemiology / Issue 3/2012
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-011-0355-y

Other articles of this Issue 3/2012

Social Psychiatry and Psychiatric Epidemiology 3/2012 Go to the issue

Original Paper

Emotional support, negative interaction and major depressive disorder among African Americans and Caribbean Blacks: findings from the National Survey of American Life

Original Paper

Alcohol misuse among partners: a potential effect modifier in the relationship between physical intimate partner violence and postpartum depression

Original Paper

Anxiety and depression in a post-September 11 sample of Arabs in the USA

Original Paper

Suicidality related to first-time admissions to psychiatric hospital

Original Paper

Impact of fetal versus perinatal hypoxia on sex differences in childhood outcomes: developmental timing matters

Original Paper

The relationship between socioeconomic position and depression among a US nationally representative sample of African Americans